Statera Biopharma Inc (STAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2006 | 12-2005 | 12-2004 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 3,062 | 1,207 | N/A |
| Marketable Securities | 1,996 | 2,382 | N/A |
| Receivables | 202 | 37 | N/A |
| Other current assets | 50 | 5 | 0 |
| TOTAL | $5,745 | $3,854 | $N/A |
| Non-Current Assets | |||
| PPE Net | 404 | 311 | N/A |
| Other Non-Current Assets | 268 | 88 | 0 |
| TOTAL | $672 | $399 | $N/A |
| Total Assets | $6,417 | $4,253 | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 645 | 265 | 0 |
| Accrued Expenses | 129 | 29 | N/A |
| TOTAL | $773 | $394 | $N/A |
| Non-Current Liabilities | |||
| Long Term Debt | 50 | N/A | N/A |
| Deferred Revenues | N/A | 100 | N/A |
| Other Non-Current Liabilities | 0 | 303 | 0 |
| TOTAL | $50 | $303 | $N/A |
| Total Liabilities | $823 | $697 | $N/A |
| Shareholders' Equity | |||
| Shares Outstanding, K | 594 | N/A | N/A |
| Common Shares | 59 | 32 | N/A |
| Retained earnings | -12,776 | -5,185 | N/A |
| Other shareholders' equity | -4 | 5,372 | 0 |
| TOTAL | $5,593 | $3,557 | $N/A |
| Total Liabilities And Equity | $6,417 | $4,253 | $0 |